Daiichi Sankyo
Michael Gordon, PhD, currently serves as the Director of Field Medical Affairs in Oncology at Daiichi Sankyo, Inc. since December 2020, after holding the position of Principal Medical Science Liaison in Oncology. Prior experience includes a role as Senior Medical Science Liaison in Oncology at AbbVie from March 2017 to December 2020 and as a Postdoctoral Research Fellow at the University of Colorado from November 2013 to March 2017. Additionally, Michael Gordon served as Adjunct Faculty at Regis University in early 2016 and held research positions at the University of Southern California, including Graduate Research Assistant and Research Associate, from 2003 to 2013. Michael Gordon earned a PhD in Pathobiology and an M.S. in Cell and Neurobiology from the University of Southern California, following a B.A. in English from Colgate University.
This person is not in any teams
This person is not in any offices
Daiichi Sankyo
21 followers
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries. The Ranbaxy Group segment includes its core company, Ranbaxy Laboratories Ltd. Both group segments deal with business activities in prescription drugs and general pharmaceutical products. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.